News

UK Health Secretary Matt Hancock has said there is a mutated form of SARS-CoV-2 that may be causing a rise in infections in South East England. According to the UK’s Health Secretary Matt Hancock, there is a new variant of...

CPI, FUJIFILM Diosynth Biotechnologies and Teesside University announced a collaboration to accelerate the bioscience sector in the Tees Valley Region. Named the Northern Bio-Accelerator Partnership (NBioP), the new collaboration will create a bioprocessing, biomanufacturing and biopharmaceutical hub in the...

GCSA launched with a commitment to increase clinical research and trial capacity and quality in the UK as well as Globally. This will be achieved through the introduction of an industry leading standard for improving, maintaining and accrediting clinical...

Fusion Antibodies, pre-clinical antibody discovery, engineering and supply experts, and Queen’s University Belfast, leader in innovation and impact, have been awarded a £453,000 grant from Invest Northern Ireland to further expand their COVID-19 targeted research and development efforts. Within...

Russia’s Sputnik V vaccine has demonstrated an efficacy of over 90 percent, according to the Gamaleya Center and the Russian Direct Investment Fund. “Evaluation of efficacy was carried out among volunteers 21 days after receiving the first dose of the...

Biogen and Eisai, Co., Ltd. announced that Biogen has submitted a Japanese New Drug Application (J-NDA) to the Ministry of Health, Labor and Welfare (MHLW) for aducanumab, an investigational therapy for Alzheimer’s disease. Aducanumab, an amyloid beta-targeting antibody, has...

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced that the U.S. government has exercised its option to purchase an additional 100 million doses of...